1. 439 Dual modes of action for anti-TIM-3 antibody MBG453 in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML): preclinical evidence for immune-mediated and anti-leukemic activity. (10th December 2020) Authors: Sabatos-Peyton, Catherine; Longmire, Tyler; Baker, Lisa; Patel, Nidhi; Wavreille, Anne-Sophie; Verneret, Melanie; Jayaraman, Pushpa; Jiang, Xiaomo; Schwartz, Stephanie; Cremasco, Viviana; Lu, Hongbo; Qiu, Shumei; Sharp, Fiona; Rinne, Mikael; Dranoff, Glenn Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗